Dysregulated Smooth Muscle Cell BMPR2–ARRB2 Axis Causes Pulmonary Hypertension
Circulation Research · 03.03.2023 · 132 (5) · 545-564
DOI: 10.1161/circresaha.121.320541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 03.03.2023. Verfasst von Lingli Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: BASE Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital (L.W., J.R.M., A.C., S.I., M.R.), Stanford University …. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Objective
Mutations in BMPR2 (bone morphogenetic protein receptor 2) are associated with familial and sporadic pulmonary arterial hypertension (PAH). The functional and molecular link between loss of BMPR2 in pulmonary artery smooth muscle cells (PASMC) and PAH pathogenesis warrants further investigation, as most investigations focus on BMPR2 in pulmonary artery endothelial cells. Our goal was to determine whether and how decreased BMPR2 is related to the abnormal phenotype of PASMC in PAH.
Methods
SMC-specific Bmpr2 −/− mice ( BKO SMC ) were created and compared to controls in room air, after 3 weeks of hypoxia as a second hit, and following 4 weeks of normoxic recovery. Echocardiography, right ventricular systolic pressure, and right ventricular hypertrophy were assessed as indices of pulmonary hypertension. Proliferation, contractility, gene and protein expression of PASMC from BKO SMC mice, human PASMC with BMPR2 reduced by small interference RNA, and PASMC from PAH patients with a BMPR2 mutation were compared to controls, to investigate the phenotype and underlying mechanism.
Results
BKO SMC mice showed reduced hypoxia-induced vasoconstriction and persistent pulmonary hypertension following recovery from hypoxia, associated with sustained muscularization of distal pulmonary arteries. PASMC from mutant compared to control mice displayed reduced contractility at baseline and in response to angiotensin II, increased proliferation and apoptosis resistance. Human PASMC with reduced BMPR2 by small interference RNA, and PASMC from PAH patients with a BMPR2 mutation showed a similar phenotype related to upregulation of pERK1/2 (phosphorylated extracellular signal related kinase 1/2)-pP38-pSMAD2/3 mediating elevation in ARRB2 (β-arrestin2), pAKT (phosphorylated protein kinase B) inactivation of GSK3-beta, CTNNB1 (β-catenin) nuclear translocation and reduction in RHOA (Ras homolog family member A) and RAC1 (Ras-related C3 botulinum toxin substrate 1). Decreasing ARRB2 in PASMC with reduced BMPR2 restored normal signaling, reversed impaired contractility and attenuated heightened proliferation and in mice with inducible loss of BMPR2 in SMC, decreasing ARRB2 prevented persistent pulmonary hypertension.
Conclusions
Agents that neutralize the elevated ARRB2 resulting from loss of BMPR2 in PASMC could prevent or reverse the aberrant hypocontractile and hyperproliferative phenotype of these cells in PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BASE Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital (L.W., J.R.M., A.C., S.I., M.R.), Stanford University School of Medicine, CA.
- Vera Moulton Wall Center for Pulmonary Vascular Diseases (L.W., J.R.M., A.C., S.I., C.G.L., N.F.T., S.T., P.-I.C., M.G., D.L., R.L.H., N.E.-B., Y.M.K., M.R.), Stanford University School of Medicine, CA.
- Stanford Cardiovascular Institute (L.W., J.R.M., A.C., S.I., C.G.L., S.T., D.P.M., P.-I.C., M.G., D.L., R.L.H., M.R.), Stanford University School of Medicine, CA.
- Department of Pediatrics (Cardiology) (L.W., J.R.M., A.C., S.I., C.G.L., N.F.T., S.T., P.-I.C., M.G., D.L., R.L.H., N.E.-B., Y.M.K., M.R.), Stanford University School of Medicine, CA.
- Department of Genetics (D.P.M.), Stanford University School of Medicine, CA.
- Department of Medicine (K.S.); Stanford University School of Medicine, CA.
ORCID-Profile: Jan-Renier Moonen, Mingxia Gu, Rebecca L Harper, Nesrine El-Bizri, Marlene Rabinovitch
Förderung
- NHLBI NIH HHS
- NCRR NIH HHS
Zitieren
APA
Wang, L., Moonen, J. R., Cao, A., Isobe, S., Li, C. G., Tojais, N. F., Taylor, S., Marciano, D. P., Chen, P. I., Gu, M., Li, D., Harper, R. L., El-Bizri, N., Kim, Y. M., Stankunas, K., & Rabinovitch, M. (2023). Dysregulated Smooth Muscle Cell BMPR2–ARRB2 Axis Causes Pulmonary Hypertension. Circulation Research, 132(5), 545-564. https://doi.org/10.1161/circresaha.121.320541
Vancouver
Wang L, Moonen JR, Cao A, Isobe S, Li CG, Tojais NF, et al. Dysregulated Smooth Muscle Cell BMPR2–ARRB2 Axis Causes Pulmonary Hypertension. Circulation Research. 2023;132(5):545-564. doi:10.1161/circresaha.121.320541
BibTeX
@article{Wang2023,
author = {Wang, Lingli and Moonen, Jan-Renier and Cao, Aiqin and Isobe, Sarasa and Li, Caiyun G and Tojais, Nancy F and Taylor, Shalina and Marciano, David P and Chen, Pin-I and Gu, Mingxia and Li, Dan and Harper, Rebecca L and El-Bizri, Nesrine and Kim, Yu-Mee and Stankunas, Kryn and Rabinovitch, Marlene},
title = {Dysregulated Smooth Muscle Cell BMPR2–ARRB2 Axis Causes Pulmonary Hypertension},
journal = {Circulation Research},
year = {2023},
volume = {132},
number = {5},
pages = {545--564},
doi = {10.1161/circresaha.121.320541}
}
EUVIMED